Healthcare -
Biotechnology - NASDAQ - US
$ 14.52
-6.02 %
$ 1.1 B
Market Cap
-5.04
P/E
NRIX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NRIX - Nurix Therapeutics, Inc.
486 M
LAST VALUE
103.57%
2 YEAR CAGR
421.43%
5 YEAR CAGR
0.00%
10 YEAR CAGR